ASH's SAS specializes in one-on-one and small group discussions.(Spotlight on hematology)

The American Society of Hematology (ASH) hosts its seventh state-of-the-art symposium (SAS) on "Recent Advances in Hematologic Malignancies and Platelet Disorders" from Sept. 11-12, 2009, at the Hilton Chicago. The 2009 SAS program will focus on the latest research and treatment options for hematologic malignancies and platelet disorders.

Attendance is limited, allowing for ample one-on-one and small-group discussion time with expert speakers and colleagues. Ask ASH's distinguished speakers about new treatment approaches, solutions for day-to-day cases, or diagnosis and management of malignant and non-malignant blood disorders. Participate in clinically I focused updates on these important issues and the latest j developments in the hematology field.

This meeting is presented in partnership with the Illinois Medical Oncology Society, Indiana Medical Oncology Society, Iowa Oncology Society, Michigan Society of Hematology and Oncology, and the Missouri Cancer Coalition. For registration and housing information, go to https://store.hematology.org.

Edited by Louise Townsend

Louise Townsend is a Florida-based writer who formerly specialized in legislative issues for a major Washington, DC, pharmaceutical association.

Print Get the Mag Weekly Updates